β¨ Education and Health Notices
2834 NEW ZEALAND GAZETTE, No. 105 19 AUGUST 2010
An integration agreement has been signed between the Minister of Education on behalf of Her Majesty The Queen, acting through the Group Manager, Education Curriculum and Performance, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:
Southland Adventist Christian School, Invercargill (4112).
The said supplementary integration agreement was executed on 12 August 2010.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the regional office of the Ministry of Education, 190 Forth Street, Invercargill.
Dated at Wellington this 12th day of August 2010.
JEREMY WOOD, Group Manager, Education Curriculum and Performance.
go6456
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Claratyne Liqui-Gels
Active Ingredient: Loratadine 10mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Catalent Pharma Solutions LLC, Florida, United States of America
Product: Clopidev
Active Ingredient: Clopidogrel besilate 111.85mg equivalent to 75mg clopidogrel
Dosage Form: Film coated tablet
New Zealand Sponsor: Deva Holdings NZ Limited
Manufacturer: Acino Pharma AG, Liesberg, Switzerland
Product: Duropatch
Active Ingredient: Fentanyl 1.28mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Technologies, Vermont, United States of America
Product: Duropatch
Active Ingredient: Fentanyl 2.55mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Technologies, Vermont, United States of America
Product: Duropatch
Active Ingredient: Fentanyl 5.1mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Technologies, Vermont, United States of America
Product: Duropatch
Active Ingredient: Fentanyl 7.65mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Technologies, Vermont, United States of America
Product: Duropatch
Active Ingredient: Fentanyl 10.2mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Technologies, Vermont, United States of America
Next Page →
β¨ LLM interpretation of page content
π Supplementary Integration Agreement for Southland Adventist Christian School
π Education, Culture & Science12 August 2010
Integration Agreement, Southland Adventist Christian School, Invercargill, Ministry of Education
- JEREMY WOOD, Group Manager, Education Curriculum and Performance
π₯ Consent to Distribution of New Medicines
π₯ Health & Social WelfareMedicines Act 1981, New Medicines, Distribution, Health, Pharmaceuticals
- Minister of Health
NZ Gazette 2010, No 105